This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US SEC should examine how China might be exploiting opaque corporate structures, senators say

By Neil Roland ( March 20, 2026, 20:28 GMT | Insight) -- The US Securities and Exchange Commission should examine how China might be exploiting murky corporate structures called variable interest entities, which may be used by hundreds of Chinese companies listed on US exchanges, a bipartisan group of senators said. These opaque structures leave investors with little insight into the entity’s true ownership structure, offering shareholders little right to meaningfully participate in its corporate decision-making and little or no legal protection, 18 members of the Senate Banking Committee wrote in a letter to SEC Chair Paul Atkins.The US Securities and Exchange Commission should examine how China might be exploiting murky corporate structures called variable interest entities, or VIEs, which may be used by hundreds of Chinese companies listed on US exchanges, a bipartisan group of senators said Thursday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login